166 related articles for article (PubMed ID: 35684457)
1. Dual-Template Magnetic Molecularly Imprinted Polymer for Simultaneous Determination of Spot Urine Metanephrines and 3-Methoxytyramine for the Diagnosis of Pheochromocytomas and Paragangliomas.
Zeng H; Zhang X; Zhen Q; He Y; Wang H; Zhu Y; Sun Q; Ding M
Molecules; 2022 May; 27(11):. PubMed ID: 35684457
[TBL] [Abstract][Full Text] [Related]
2. Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas.
Wang H; Zhang X; Zhen Q; Zou W; Chen H; Luo C; Ding M
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1156():122306. PubMed ID: 32829134
[TBL] [Abstract][Full Text] [Related]
3. High specificity of spot urinary free metanephrines in diagnosis and prognosis of pheochromocytomas and paragangliomas by HPLC with electrochemical detection.
Zuo M; Zhen Q; Zhang X; Zou W; Yang X; Tian G; Shi Z; Li Q; Ding M
Clin Chim Acta; 2018 Mar; 478():82-89. PubMed ID: 29273559
[TBL] [Abstract][Full Text] [Related]
4. Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
Wang K; Gao X; Cong H; Zhang W; Shi X; Dai S; Zhou Z
Endocrine; 2020 Jul; 69(1):188-195. PubMed ID: 32222878
[TBL] [Abstract][Full Text] [Related]
5. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
[TBL] [Abstract][Full Text] [Related]
6. Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.
Sbardella E; Maunsell Z; May CJH; Tadman M; James T; Jafar-Mohammadi B; Isidori AM; Grossman AB; Shine B
Eur J Endocrinol; 2020 Aug; 183(2):129-139. PubMed ID: 32413848
[TBL] [Abstract][Full Text] [Related]
7. A 3-min UPLC-MS/MS method for the simultaneous determination of plasma catecholamines and their metabolites: Method verification and diagnostic efficiency.
Jian M; Huang H; Li K; Chuan L; Li L; Jiang L
Clin Biochem; 2021 Jan; 87():67-73. PubMed ID: 33096053
[TBL] [Abstract][Full Text] [Related]
8. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
Peitzsch M; Prejbisz A; Kroiß M; Beuschlein F; Arlt W; Januszewicz A; Siegert G; Eisenhofer G
Ann Clin Biochem; 2013 Mar; 50(Pt 2):147-55. PubMed ID: 23512172
[TBL] [Abstract][Full Text] [Related]
9. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
10. An automated magnetic bead extraction method for measuring plasma metanephrines and 3-methoxytyramine using liquid chromatography tandem mass spectrometry.
Yu S; Zhou W; Yu J; Li M; Zhang S; Jiang X; Wang H; Ma X; Zou Y; Wang D; Cheng Q; Xie S; Luo W; Guo X; Qiu L
Anal Bioanal Chem; 2022 May; 414(11):3541-3549. PubMed ID: 35234981
[TBL] [Abstract][Full Text] [Related]
11. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z
Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657
[TBL] [Abstract][Full Text] [Related]
12. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
[TBL] [Abstract][Full Text] [Related]
13. An LC-MRM assay for the quantification of metanephrines from dried blood spots for the diagnosis of pheochromocytomas and paragangliomas.
Richard VR; Zahedi RP; Eintracht S; Borchers CH
Anal Chim Acta; 2020 Sep; 1128():140-148. PubMed ID: 32825898
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry.
Willemsen JJ; Ross HA; Wolthers BG; Sweep CG; Kema IP
Ann Clin Biochem; 2001 Nov; 38(Pt 6):722-30. PubMed ID: 11732660
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of single-voided urine metanephrine and normetanephrine assay for diagnosing pheochromocytoma.
Ito Y; Obara T; Okamoto T; Kanbe M; Tanaka R; Iihara M; Okamoto J; Yamazaki K; Jibiki K
World J Surg; 1998 Jul; 22(7):684-8. PubMed ID: 9606282
[TBL] [Abstract][Full Text] [Related]
16. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
[TBL] [Abstract][Full Text] [Related]
17. Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.
Bokuda K; Yatabe M; Seki Y; Ichihara A
Hypertens Res; 2020 Jun; 43(6):543-549. PubMed ID: 32020083
[TBL] [Abstract][Full Text] [Related]
18. Selective extraction and determination of catecholamines in urine samples by using a dopamine magnetic molecularly imprinted polymer and capillary electrophoresis.
Bouri M; Lerma-García MJ; Salghi R; Zougagh M; Ríos A
Talanta; 2012 Sep; 99():897-903. PubMed ID: 22967640
[TBL] [Abstract][Full Text] [Related]
19. Laboratory evaluation of pheochromocytoma and paraganglioma.
Eisenhofer G; Peitzsch M
Clin Chem; 2014 Dec; 60(12):1486-99. PubMed ID: 25332315
[TBL] [Abstract][Full Text] [Related]
20. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
